Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2026)

Kiniksa Pharmaceuticals International (KNSA) has reported Change in Inventory for 6 consecutive years, with -$2.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory fell 108.47% year-over-year to -$2.2 million; the trailing twelve-month figure through Jun 2026 stood at $22.7 million (up 70.75% YoY), and the FY2025 full-year result was $28.5 million, up 699.64% from the prior year.
• Change in Inventory eased to -$2.2 million in Q2 2026 per KNSA's latest filing, from $18.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $26.1 million in Q2 2025 and bottomed at -$6.8 million in Q3 2025.
• Historically, Change in Inventory has averaged $3.7 million across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Inventory plunged 583.23% in 2022, then soared 1322.14% in 2024.
• Over 5 years, Change in Inventory stood at $7.0 million in 2022, then dropped by 20.62% to $5.5 million in 2023, then tumbled by 141.81% to -$2.3 million in 2024, then soared by 682.86% to $13.5 million in 2025, then sank by 116.38% to -$2.2 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$2.2 million, $18.2 million, and $13.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.